All News
49ers’ Jon Feliciano supports MAPS as part of the 2023 NFL “My Cleats, My Cause” campaign
FOR IMMEDIATE RELEASE: December 4, 2023 Yesterday’s highly anticipated football game between the San Francisco 49ers and the Philadelphia Eagles brought additional excitement to the field thanks to 49ers’ …
Creating Pathways: History and the Impact of Health Care for Native Americans in the Psychedelic Renaissance
From the MAPS Bulletin 2023: Vol 33, No. 3
About the Cover Artist Karina Alvarez From the Desk of Rick Doblin, Ph.D Rick Doblin, Ph.D Not Like a Trip Away:Proper Relationship With Plant Medicines TysonYunkaporta Creating Pathways: History and the …
Not Like a Trip Away: Proper Relationship With Plant Medicines
BizBash: Conferences That Captivate: 10 Most Cutting-Edge Meetings of 2023
The largest psychedelic conference in history featured important conversations on the power and promise of psychedelics—along with some surreal art exhibits and tech-forward sponsor activations. Originally …
The Virtual Trip Showcases Veterans Sessions from Psychedelic Science 2023 in Honor of Veterans Day
FOR IMMEDIATE RELEASE: November 11, 2023 In honor of Veterans Day, the Multidisciplinary Association for Psychedelic Studies (MAPS) is highlighting a series of insightful discussions focused on critical …
MAPS Statement on Trauma and Crisis Response in Palestine and Israel
Many in the MAPS community are grieving the loss and suffering experienced by family, friends, colleagues, and countless others impacted by the Israel-Hamas war. At MAPS, we have been in deep dialogue …
The Mushroom’s Fourth Side Poem
PS2023: The Virtual Trip Unveils Latest Video Release Featuring Michael Pollan, Melissa Etheridge, and More
PS2023: The Virtual Trip, produced by the Multidisciplinary Association for Psychedelic Studies (MAPS), has published an additional 40 session videos from Psychedelic Science 2023, showcasing a trove of …
From the Desk of Rick Doblin, Ph.D.
MAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: September 14, 2023 Results of the second, confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder, MAPP2, have been published in Nature Medicine. MAPP2 …